Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

Part of paid clinical trials in Sioux Falls, South Dakota.

Sponsor
Vance Thompson Vision
Study ID
NCT07155057
Status
Recruiting
Apply to this trial

Conditions

  • Dry Eye Disease (DED)

Eligibility Criteria

Sex
ALL
Age
22 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML — DEVICE
    Prospective, single-site, single-arm study enrolling 60 patients who have elected advanced IOL implantation at the time of cataract surgery and have a diagnosis of dry eye disease. The study will consist of 5 study visits, over a 3-5 month time period. Patients will receive bilateral lacrimal occlusion of crosslinked hyaluronate canalicular gel pre-operatively

Study Details

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Key Dates

Start date
Sep 3, 2025
Status verified
Sep 2025
Primary completion
Jun 30, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER

Arms

  • Other: Study Participants
    Patients will receive bilateral lacrimal occlusion of crosslinked hyaluronate canalicular gel pre-operatively

Primary Outcome Measure

Change from baseline to 3- month visit in non-invasive tear break up time (NITBUT) in primary eyes as measured by a non-invasive, automated ocular surface analyzer. [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Vance Thompson Vision Clinic, Prof. LLCSioux FallsSouth Dakota57105
Tiffany R Facile
[email protected]
Kristin Dunne
[email protected]

Find similar trials in Sioux Falls, SD

By research site
Vance Thompson Vision Clinic, Prof. LLC· Sioux Falls, SD

Related Studies